ca-ssis / iStockphoto.com
The US Food and Drug Administration (FDA) has released guidance intended to advance the development of generic versions of complex medical drugs.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
US Food and Drug Administration, Scott Gottlieb, complex drugs, generic competition, Abbreviated New Drug Application, topical delivery systems